Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin.
Margaret B NolanThomas M PiaseckiStevens S SmithTimothy B BakerMichael C FioreRobert T AdsitDaniel M BoltKaren L ConnerSteven L BernsteinOliver S EngDavid LazukAlec GonzalezTodd Hayes-BirchlerDouglas E JorenbyHeather D'AngeloJulie A KirschBrian S WilliamsSean KentHanna KimStanley A LubanskiMenggang YuYoumi SukYuxin CaiNitu KashyapJomol MathewGabriel McMahanBetsy RollandHilary A TindleGraham W WarrenNoor Abu-El-RubLawrence C AnAndrew Dallas BoydDarlene H BrunzellVictor A CarrilloLi-Shiun ChenJames M DavisVikrant G DeshmukhDeepika DilipAdam O GoldsteinPatrick K HaEduardo IturrateThulasee JoseNiharika KhannaAndrea C KingElizabeth KlassMichelle LuiRobin J MermelsteinChester PoonElisa K TongKaren M WilsonWendy E TheobaldWendy S SlutskePublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2022)
This study clarifies the characteristics that modify the risk associated with cancer on severe COVID-19 outcomes across the first 20 months of the COVID-19 pandemic.